Hour24 News

Sophisticated and simple

NEWS

/

News & Medical Research

Jan 27, 2026

News & Medical Research /

Sarepta’s ELEVIDYS Demonstrates Slowed Disease Progression in Ambulatory Duchenne Patients: Positive EMBARK Topline Three-Year Results

New EMBARK topline results highlight a meaningful impact of ELEVIDYS in ambulatory Duchenne patients Sarepta Therapeutics today reported positive topline results from three years of…